LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 01, 2024 18:32 ET
|
LENSAR, Inc.
ORLANDO, Fla., Nov. 01, 2024 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”) today announced that a majority of the independent members of LENSAR’s board of directors...
LENSAR to Report Third Quarter 2024 Financial Results on Thursday, November 7, 2024
October 31, 2024 07:00 ET
|
LENSAR, Inc.
ORLANDO, Fla., Oct. 31, 2024 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced robotic laser solutions for the...
One Millionth Procedure Completed Using LENSAR’s Cataract Laser Systems
October 08, 2024 08:00 ET
|
LENSAR, Inc.
ORLANDO, Fla., Oct. 08, 2024 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced robotic laser solutions for the...
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 01, 2024 18:25 ET
|
LENSAR, Inc.
ORLANDO, Fla., Oct. 01, 2024 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”) today announced that a majority of the independent members of LENSAR’s board of directors...